Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals

▤ Summary

Kadima Neuropsychiatry Institute has filed suit against NRx Pharmaceuticals. The item is a brief Reuters-linked legal notice and does not describe a product, financing round, or corporate transaction. The dispute still matters to software and life sciences readers because it involves a pharma-sector company. No operational or commercial changes are described in the article itself.

▦ Linked Companies